PAR 12.7% 31.0¢ paradigm biopharmaceuticals limited..

Timetable Update, page-21

  1. 253 Posts.
    lightbulb Created with Sketch. 33
    once again,

    The share price is not going to plummet $2 just because there has been a 3 week delay in Dr Michel receiving IPPS. Where does it stipulate a date in which the Phase iii trails will begin in the asx media release which was submitted on the 10th of September ??
    it states trials will begin sometime Q4 CY19

    not within the coming weeks of dr Michel being appointed??

    what is wrong with your head
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.